KCM
HUMA icon

Kodai Capital Management’s Humacyte HUMA Stock Holding History

Kodai Capital Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$124K Buy
+72,565
New +$272K ﹤0.01% 145

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Kodai Capital Management's HUMA Position: Q1 2025 in Review

Kodai Capital Management opened a new position in Humacyte (HUMA) in Q1 2025: 72,565 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #145 among its holdings.

168 funds tracked by Wall St. Rank hold HUMA as of Q1 2025.

  • Kodai Capital Management held 72,565 shares of Humacyte worth $124K as of Q1 2025.
  • Humacyte was a new Kodai Capital Management position in Q1 2025.
  • Humacyte made up ﹤0.01% of Kodai Capital Management's portfolio in Q1 2025, its #145 holding.
  • 168 funds tracked by Wall St. Rank held Humacyte as of Q1 2025.

Based on Kodai Capital Management's 13F filing for Q1 2025, filed 15 May 2025.